BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31258978)

  • 1. Detecting Signals of Dietary Supplement Adverse Events from the CFSAN Adverse Event Reporting System (CAERS).
    Vasilakes JA; Rizvi RF; Zhang J; Adam TJ; Zhang R
    AMIA Jt Summits Transl Sci Proc; 2019; 2019():258-266. PubMed ID: 31258978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
    Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
    Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.
    Li W; Wertheimer A
    Innov Pharm; 2023; 14(1):. PubMed ID: 38035313
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of FDA adverse event report data to the surveillance of dietary botanical supplements.
    Wallace RB; Gryzlak BM; Zimmerman MB; Nisly NL
    Ann Pharmacother; 2008 May; 42(5):653-60. PubMed ID: 18397972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everyday Evaluation of Herb/Dietary Supplement-Drug Interaction: A Pilot Study.
    Souza-Peres JV; Flores K; Umloff B; Heinan M; Herscu P; Babos MB
    Medicines (Basel); 2023 Feb; 10(3):. PubMed ID: 36976309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.
    Raschi E; Girardi A; Poluzzi E; Forcesi E; Menniti-Ippolito F; Mazzanti G; De Ponti F
    Drug Saf; 2018 Aug; 41(8):745-752. PubMed ID: 29582393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the FDA adverse event reporting system and the potential for reporting bias.
    Monnot AD; Fung ES; Compoginis GS; Towle KM
    J Cosmet Dermatol; 2021 Jun; 20(6):1849-1854. PubMed ID: 33713536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplement adverse events: report of a one-year poison center surveillance project.
    Haller C; Kearney T; Bent S; Ko R; Benowitz N; Olson K
    J Med Toxicol; 2008 Jun; 4(2):84-92. PubMed ID: 18570167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.
    Wang Y; Gunashekar DR; Adam TJ; Zhang R
    Stud Health Technol Inform; 2017; 245():614-618. PubMed ID: 29295169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide Online Survey Method to Estimate Ongoing Adverse Events Caused by Supplement Use: Application to Diarrhea.
    Nishijima C; Chiba T; Sato Y; Yamada H; Umegaki K
    Shokuhin Eiseigaku Zasshi; 2018; 59(3):106-113. PubMed ID: 30033986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Term Coverage of Dietary Supplements Ingredients in Product Labels.
    Wang Y; Adam TJ; Zhang R
    AMIA Annu Symp Proc; 2016; 2016():2053-2061. PubMed ID: 28269965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the Dietary Supplement Label Database to Identify Potentially Harmful Dietary Supplement Ingredients.
    Scott JM; Lindsey AT; Costello RB; Deuster PA
    Nutr Today; 2018; 53(5):229-233. PubMed ID: 30774152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide Online Survey to Complement the Current Voluntary Reporting System for Adverse Events Associated with Dietary Supplements: Application to the Case of Skin Manifestations.
    Nishijima C; Sato Y; Chiba T; Umegaki K
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(4):277-283. PubMed ID: 30175791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of adverse event reporting and signal generation of dietary supplements in Korea.
    Park KS; Kwon O
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):74-7. PubMed ID: 20074608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database.
    Soukavong M; Kim J; Park K; Yang BR; Lee J; Jin XM; Park BJ
    J Korean Med Sci; 2016 Sep; 31(9):1355-61. PubMed ID: 27510377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
    Liu R; Zhang P
    BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplement adverse event reports: review and analysis.
    Talati AR; Gurnani AK
    Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).
    Wei L; Scott J
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):922-33. PubMed ID: 26045284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.